Money, IP, and the people you let in: what mass spec founders and investors shared with a room full of scientists
ASMS 2026, San Diego. Workshop edition.
Scientific deep dives, product thinking, and perspectives on proteomics, reproducibility, and agent-ready science — from the team building Mass Dynamics.
ASMS 2026, San Diego. Workshop edition.
My training is as a protein biochemist, with detours through immunology, virology, and proteomics. My last academic role was building a ...
The room was mostly PhD students, postdocs, facility managers, and scientists. People who may or may not have started a company but were ...
It wasn’t a trade show or a marketing showcase. The room was intimate - directors, VPs, heads of platform, chemists, bioinformaticians. The ...
Proteomics is at an inflection point. Not one that will be resolved by faster instruments, cheaper compute, or another exponential curve on ...
Why We Ran CONNECT: Boston
Discovery
Core fishbowl panelists and facilitators (left to right): Paula Burton, Chiara Guerrera, Harris Bell-Temin, Olga Vitek, Joey Latham, Andrew ...
I’ve spent nearly two decades navigating the tsunami of data - first as an academic proteomics lead, now as a founder building platforms to ...
Proteomics is accelerating. Can our current tools keep up?
Introduction: The Urgency of Multivariate Companion Markers in Precision Medicine
Introduction: A Paradigm Shift in Drug Discovery